Interviews
Video by Huberman Lab Clips. Watch on YouTube ↗
Summary
Neuroscientist and meditation teacher Sam Harris joins Andrew Huberman to explain why he considers psychedelics useful: not as an end in themselves, but as a doorway into taking first-person experience seriously. Drawing on a clinical MDMA trial and decades of meditation practice, he distinguishes MDMA from classic, perception-altering psychedelics like LSD and psilocybin. His central point is that the value of these experiences lies less in the altered state itself than in what carries over into ordinary consciousness afterward.
Harris leads with the conditions he says make psychedelic use responsible: safety, legality, age and context appropriateness, and ideally clinical guidance. Anyone with a personal or family history suggestive of schizophrenia or bipolar disorder is, in his words, "almost certainly" not a good candidate; trials at Johns Hopkins, he notes, screen out participants with first-degree relatives who have these conditions.
He pushes back on the single term "psychedelics," since it groups pharmacologically different substances. MDMA, he says, is an amphetamine derivative, sometimes called an entactogen: serotonergic, but without the perceptual distortion of LSD or psilocybin. He took part in a clinical trial of three MDMA doses, near the MAPS research dose (about 125 milligrams with an optional 75 milligram booster), and says it produced lasting, valuable learning. An MDMA experience around age 18 convinced him, a self-described hard-headed skeptic, that exploring the mind firsthand was worth pursuing: he recalls a failed attempt to guide Richard Dawkins through meditation on his podcast, for lack of any prior interest pulling Dawkins's attention inward, unlike a sufficient psychedelic dose, where he says something happens almost every time.
Under appropriate set and setting, Harris says these experiences often reveal states like unconditional love or a felt oneness with nature, though the memory fades quickly, "like trying to remember a dream," and bad trips remain possible on LSD or psilocybin. He warns against chasing repeated peak experiences, calling that pursuit inherently frustrating since any altered state is, by definition, impermanent.
The more durable insight, in Harris's view, is what contemplative traditions like Buddhism point to, apart from their supernatural elements: recognizing the illusion of the self, achievable without changing the contents of experience at all. After 25 years away, he did a first-ever blindfolded, high-dose mushroom trip, describing intense synesthesia and moments where "heaven and hell," as he puts it, turned on whether he could let go of self-control, a skill he credits to mindfulness training.
Harris closes on the aim he thinks matters most: wisdom portable into ordinary life, like giving a child undistracted attention, rather than living for periodic highs. "This cup is just as formless and as mysterious," he says, framing integration, not the peak experience, as the real point.
More videos